12/17
09:23 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
12/17
08:59 am
idya
Rating for IDYA
Medium
Report
Rating for IDYA
12/17
08:35 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $52.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $52.00 price target on the stock.
12/17
08:35 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $52.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $52.00 price target on the stock.
12/17
08:30 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
12/17
08:30 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
11/18
10:24 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
11/18
08:50 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is now covered by analysts at Stephens. They set an "overweight" rating and a $51.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is now covered by analysts at Stephens. They set an "overweight" rating and a $51.00 price target on the stock.
11/18
08:50 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is now covered by analysts at Stephens. They set an "overweight" rating and a $51.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is now covered by analysts at Stephens. They set an "overweight" rating and a $51.00 price target on the stock.
11/5
07:27 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $27.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $27.00 price target on the stock.
11/5
07:19 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
11/5
12:45 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $52.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $52.00 price target on the stock.
11/5
12:45 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $52.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $52.00 price target on the stock.
10/29
12:22 pm
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $53.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $53.00 price target on the stock.
10/29
11:37 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
10/29
11:37 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
10/24
07:33 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
10/24
07:16 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $50.00 price target on the stock.
10/15
09:15 am
idya
Ideaya Biosciences initiated with bullish view at Cantor Fitzgerald
Low
Report
Ideaya Biosciences initiated with bullish view at Cantor Fitzgerald
10/15
09:02 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.